Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-543-3605
Dr. Sendaydiego is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of WisconsinClass of 2022
Certifications & Licensure
WA State Medical License 2024 - 2025
Publications & Presentations
PubMed
- Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil, James S Andrews, Pankti Reid
Rheumatology. 2025-02-12 - Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil, James S Andrews, Pankti Reid
JAMA Network Open. 2024-11-04 - 2 citationsCarvedilol Phenocopies PGC-1α Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived Ca...Nnamdi Uche, Qiang Dai, Shuping Lai, Kurt Kolander, Mai Thao
Antioxidants. 2023-08-09
Press Mentions
Do Antirheumatic Drugs Increase the Risk of Cancer?March 3rd, 2025- Rituximab and Abatacept May Contribute to Cancer Risk in Patients with Rheumatoid ArthritisDecember 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
